| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 04/16/2009 | US20090095293 Dry powder inhalation system for transpulmonary administration |
| 04/16/2009 | CA2700759A1 Benzocycloheptene derivatives as estrogens having selective activity |
| 04/15/2009 | EP2048162A1 Novel monoclonal antibody and use of the same |
| 04/15/2009 | EP2048126A1 Benzocycloheptane derivatives as selectively active oestrogens |
| 04/15/2009 | EP2046737A2 2-methylene-1 alpha,25-dihydroxy-19,21-dinorvitamin d3 analogs and uses thereof |
| 04/15/2009 | EP2046341A1 Compositions and methods for treating diabetes and neuropsychological dysfunction |
| 04/15/2009 | EP2046325A1 Phytoestrogenic formulations and uses thereof |
| 04/15/2009 | EP1660091B1 Pyrimidine-2,4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
| 04/15/2009 | EP1437140B1 Oral pharmaceutical formulation containing active carbon and use of the same |
| 04/15/2009 | EP1419143B1 24-sulfur-substituted analogs of 1alpha,25-dihydroxy vitamin d3 |
| 04/15/2009 | EP1311532B1 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase |
| 04/15/2009 | EP1161452B1 Covalently bridged insulin dimers |
| 04/15/2009 | CN101410381A Novel 2-substituted benzimidazoles as selective androgen receptor modulators (SARMs) |
| 04/15/2009 | CN101406467A 3,5,3'-triiodothyronine sulfate as thyromimetic agent and pharmaceutical formulations thereof |
| 04/15/2009 | CN101406460A Euthyrox tablet |
| 04/15/2009 | CN100477986C Ascending-dose dosage form |
| 04/14/2009 | US7517996 methyl 3-(4-{4-[1-(2-chlorophenyl)ethoxycarbonylamino]-3-isoxazolyl}-benzylsulfanyl)propionate; compounds inhibit the physiological activity of lysophosphatidic acid (LPA); treatment of fibrosis of organs (liver, kidney, lung, and the like), hepatic disease |
| 04/14/2009 | US7517987 Interleukin converting enzyme inhibitors such as 5-Fluoro-4-oxo-3-(2-(6-oxo-6H-pyrimidin-1-yl)-butyrylamino)-pentanoic acid, administered as modulators of cell apoptosis and inflammation |
| 04/14/2009 | US7517909 Using 3-amino-5-methyl-octanoic acid for therapy of psychiatric, pain and other disorders |
| 04/14/2009 | US7517686 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 04/14/2009 | US7517658 Drug screening for human SNORF33 receptor agonist by contacting cells transfected with and expressing DNA encoding the human SNORF33 receptor, wherein cells prior to being transfected with the DNA do not express the human SNORF33 receptor; inflammation, infections, arthritis; autoimmune diseases |
| 04/14/2009 | CA2219460C Lhrh antagonist peptides |
| 04/14/2009 | CA2170479C Benzothiophene compounds, intermediates, compositions, and methods |
| 04/09/2009 | WO2009044788A1 Benzoxazinone derivative |
| 04/09/2009 | WO2009044200A1 Steroidal [3, 2-c] pyrazole compounds, with glucocorticoid activity |
| 04/09/2009 | WO2008122667A3 Ureylene derivatives |
| 04/09/2009 | US20090093478 N-aroyl cyclic amines |
| 04/09/2009 | US20090093411 Long-acting hormone and growth factor compositions and uses thereof |
| 04/09/2009 | US20090092687 Prhormone composition and method of use thereof |
| 04/09/2009 | US20090092656 Method of treating atrophic vaginitis |
| 04/09/2009 | DE4021517B4 Formulierungen mit verlangsamter Freisetzung wasserlöslicher Peptide Formulations with delayed release of water-soluble peptides |
| 04/09/2009 | CA2701406A1 Benzoxazinone derivative |
| 04/09/2009 | CA2700181A1 Steroidal [3, 2-c] pyrazole compounds, with glucocorticoid activity |
| 04/08/2009 | EP2044941A1 Multiple-phase formulation of drospirenone and estradiol as a contraceptive |
| 04/08/2009 | EP2044099A2 Process for the preparation of s-fluoromethyl-6 ,9 -difluoro-11 -hydroxy-16 -methyl-17 -propionyloxy-3-oxo-androsta-1,4-diene-17 -carbothioate and intermediates |
| 04/08/2009 | EP1706114A4 Chemical inhibitors of soluble adenylyl cyclase (sac) |
| 04/08/2009 | EP1682122B9 Combinations of valsartan, amiloride or triamterine, and a diuretic |
| 04/08/2009 | EP1415986B1 Spiro isobenzofuranes as neuropeptide y receptor antagonists |
| 04/08/2009 | CN101404993A Ticonvulsant derivant used for preventing development of II type diabetes and X syndrome |
| 04/08/2009 | CN100475843C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 04/08/2009 | CN100475781C Androgen receptor modulators |
| 04/08/2009 | CN100475267C Liquid formulations with a high concentration of human growth hormone (hgh) comprising glycin |
| 04/08/2009 | CN100475216C Compound lycopene formulation for women and preparation process thererof |
| 04/07/2009 | US7514583 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| 04/07/2009 | US7514398 Growth factor complex |
| 04/07/2009 | US7514239 Nucleotide sequences coding polypeptide for use in the treatment of preferential glandular disorders |
| 04/07/2009 | US7514225 detecting drugs that inhibits the binding of macrophage migration inhibitory factor (MIF) to an antimacrophage migration inhibitor factor monoclonal or polyclonal antibody; drug screening |
| 04/07/2009 | CA2390116C Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 04/07/2009 | CA2339253C Inhibitors of p38 |
| 04/02/2009 | WO2009041714A1 External preparation for free radical diseases |
| 04/02/2009 | WO2009039943A1 (carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament |
| 04/02/2009 | WO2009039942A1 (cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament |
| 04/02/2009 | WO2008124000A3 Thiazole derivatives as androgen receptor modulator compounds |
| 04/02/2009 | US20090088480 Solid forms of selective androgen receptor modulators |
| 04/02/2009 | US20090088462 Pharmaceutical Composition for Enhancing Adiponectin Production |
| 04/02/2009 | CA2700028A1 (carboxylalkylenephenyl)phenyloxamides, method for the production thereof and use of same as a medicament |
| 04/02/2009 | CA2700025A1 (cyclopropylphenyl)phenyloxamides, method for the production thereof, and use of same as a medicament |
| 04/01/2009 | EP2042196A2 Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF) |
| 04/01/2009 | EP2040733A2 Method for elevating prolactin in mammals |
| 04/01/2009 | EP2040565A1 Copositions and methods for preventing or treating cardiovascular diseases in felines with hyperthyroidism |
| 04/01/2009 | EP1648565B1 Medicament comprising plant material from mascagnia eggersiana for treating type 2 diabetes mellitus |
| 04/01/2009 | EP1349873B1 Modulation of il-2- and il-15-mediated t cell responses |
| 04/01/2009 | EP1137666B9 Glp-1 analogues |
| 04/01/2009 | CN101396357A Use of lipoamide in preventing and treating insulin resistance |
| 04/01/2009 | CN100473405C Medicinal composition for treating hyperthyroidism |
| 03/31/2009 | US7511123 Binding to antigen; controlling concentration |
| 03/31/2009 | US7511094 2-methylbutyraldehyde diethyl acetal end capped polyoxyethylene glycol; polyalkylene oxide, polyivnylpyrrolidone, polyvinyl alcohol, polyoxazoline etc. endcapped with polyetherpolyamine copolymers or oligomers covalently attached to diacetal tetramethylene group |
| 03/31/2009 | US7511047 Kinase inhibitors |
| 03/31/2009 | US7510825 Detecting perturbations and alterations of the normal organization of the cell plasma membrane (PNOM)-cells within a population of cells using a "perturbed membrane-binding compound" (PMBC) of given formula; e.g. monitoring aggressiveness of a tumor |
| 03/31/2009 | CA2066204C Cystic fibrosis gene |
| 03/26/2009 | WO2009038057A1 Nitrogenated fused-ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes |
| 03/26/2009 | WO2009037813A1 Transdermally absorbable preparation |
| 03/26/2009 | WO2009037172A1 Prodrugs to thyroid hormone analogs |
| 03/26/2009 | WO2009016253A3 Cyanomethyl substituted n-acyl tryptamines |
| 03/26/2009 | US20090082390 Piperidine compounds for use as orexin receptor antagonist |
| 03/26/2009 | US20090081303 Pharmaceutical formulation for contraception and hormone-replacement therapy |
| 03/26/2009 | US20090081168 Method of forming a peptide-receptor complex with zsig33 |
| 03/26/2009 | DE102006050558B4 Transdermales therapeutisches System enthaltend Norelgestromin zur Kontrazeption und Hormonsubstitution Transdermal therapeutic system containing norelgestromin contraceptive and hormone replacement |
| 03/26/2009 | CA2699338A1 Prodrugs to thyroid hormone analogs |
| 03/25/2009 | EP2039702A2 Prodrugs erbeta-selective substances, method for their production and pharmaceutical compounds containing these compositions |
| 03/25/2009 | EP2039701A2 20-keto-11beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 03/25/2009 | EP2039700A2 Novel anti-inflammatory androstane derivatives |
| 03/25/2009 | EP2038294A1 18-methyl-19-nor-androst-4-en-17,17-spiroether (18-methyl-19-nor-20- spirox-4-en-3-one) and pharmaceutical preparations containing the same |
| 03/25/2009 | EP2037936A2 Method of treating and preventing secondary hyperparathyroidism |
| 03/25/2009 | EP2037905A2 Treatment of vasomotor symptoms with selective estrogen receptor modulators |
| 03/25/2009 | EP1846434B1 NANDROLONE 17ß-CARBONATES |
| 03/25/2009 | EP1555265B1 7-phenyl pyrazolopyridine compounds |
| 03/25/2009 | EP1287035B1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 03/25/2009 | CN101394841A Fast-acting oral peptide pharmaceutical products |
| 03/24/2009 | US7507706 Administering a polypeptide to reduce airway hyper responsiveness or reduce the increase of mucus-containing cells in the airway epithelium; IL-13 binding chains of the interleukin-13 receptor |
| 03/24/2009 | US7507414 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
| 03/24/2009 | CA2606275C Method for preparing and using water-based steroid pheromone compositions |
| 03/24/2009 | CA2422380C Pyrazole compounds useful as protein kinase inhibitors |
| 03/24/2009 | CA2382404C Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 03/19/2009 | WO2009035068A1 Novel 1,3,3-trimethyl-7-phenyl-3,4-dihydro-1h-quinoxalin- 2-one derivatives |
| 03/19/2009 | WO2009035067A1 Glucocorticoid receptor agonists consisting of 1,3,3-tri- methyl-7-phenyl-3,4-dihydro-1h-quinoxalin-2-one derivatives |
| 03/19/2009 | WO2009034325A1 Isoflavone formulation |
| 03/19/2009 | WO2009033212A1 The use of estrogen and androgen binding proteins in methods and compositions for treating gynaecological cancers |
| 03/19/2009 | US20090075997 Deuterium-enriched satavaptan |
| 03/19/2009 | US20090075981 INHIBITORS OF p38 |